Triple
T4871029
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Indian National Army trials |
E109084
|
entity |
| Predicate | alsoKnownAs |
P39
|
FINISHED |
| Object |
INA trials
INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
|
E475967
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: INA trials | Statement: [Indian National Army trials, alsoKnownAs, INA trials]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: INA trials Context triple: [Indian National Army trials, alsoKnownAs, INA trials]
-
A.
APHINITY trial
The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
-
B.
CLEOPATRA trial
The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
-
C.
ENSEMBLE trial
The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
-
D.
Nuremberg follow-up trials planning
Nuremberg follow-up trials planning refers to the post–World War II legal and logistical preparations for subsequent war crimes prosecutions beyond the main Nuremberg Trial.
-
E.
RCT
RCT is the abbreviation for the Royal Corps of Transport, a former corps of the British Army responsible for military transport and logistics.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: INA trials Triple: [Indian National Army trials, alsoKnownAs, INA trials]
Generated description
INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: INA trials Target entity description: INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
-
A.
APHINITY trial
The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
-
B.
CLEOPATRA trial
The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
-
C.
ENSEMBLE trial
The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
-
D.
Nuremberg follow-up trials planning
Nuremberg follow-up trials planning refers to the post–World War II legal and logistical preparations for subsequent war crimes prosecutions beyond the main Nuremberg Trial.
-
E.
RCT
RCT is the abbreviation for the Royal Corps of Transport, a former corps of the British Army responsible for military transport and logistics.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd440d96a48190b0c87069adef2af1 |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd6d9c77b88190b3e6884c9752ebbb |
completed | March 20, 2026, 3:54 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69be67f1ca1881909a7412087fa0efab |
completed | March 21, 2026, 9:42 a.m. |
| NEDg | Description generation | batch_69be68b9300c8190ba829be08e520047 |
completed | March 21, 2026, 9:45 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69be6961d8688190a041e476e082ac36 |
completed | March 21, 2026, 9:48 a.m. |
Created at: March 20, 2026, 1:27 p.m.